Neurofeedback therapy for food addiction in obese individuals

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the use of neurofeedback based on near-infrared spectroscopy (fNIRS) to enhance brain activity in the dorsolateral prefrontal cortex (dlPFC) of obese individuals with food addiction. Participants will undergo eight neurofeedback sessions over a month, aiming to improve their eating behaviors and promote long-term weight loss. The effectiveness of this intervention will be assessed through clinical data and questionnaires, comparing results from the start of the study to three months later.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Eligible for obesity surgery according to the 2009 French High Authority on Health (HAS) criteria (BMI ≥40 or BMI ≥35 with comorbidities)
* Right-handed
* Presenting a food addiction determined by the YFAS 2.0 questionnaire ;
* Affiliated to a social security system;
* Having given free and informed consent in writing.

Exclusion Criteria:

* Psychotic psychiatric disorders (schizophrenic disorders and bipolar disorders);
* Psychotropic drugs, except antidepressants stabilized for at least 3 weeks and benzodiazepines
* Addiction to alcohol or other psychoactive substances (except tobacco);
* History of bariatric surgery;
* Current treatment in the nutrition unit;
* Insufficient command of French;
* Pregnant or breast-feeding woman;
* Persons of legal age under legal protection (safeguard of justice, curatorship, guardianship), persons deprived of liberty.
* Contraindications to fMRI
* Inability to perform the fNIRS procedure due to blockage or attenuation of the light at the capillary level

Where it's running

• CHU Rennes
  Rennes, France Recruiting

Study contacts

• Study coordinator: Marie-Laure GERVAIS
• Email: marie-laure.gervais@chu-rennes.fr
• Phone: 0618454735

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Ocular Changes in People Using Tirzepatide or Semaglutide

  This study checks whether eye structure and blood vessels change in adults with obesity who are taking semaglutide or tirzepatide as part of routine care.

  Recruiting Istanbul University · Istanbul, Istanbul · NCT07924618

• Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes

  This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.

  Recruiting Pamukkale University · Denizli · NCT07924436

• Berobenatide for knee pain in adults who are overweight or with obesity

  This study tests berobenatide vs. placebo to see if it reduces knee pain and improves function while helping with weight in adults with knee osteoarthritis and overweight/obesity.

  Recruiting at 7 sites Phase 3 Pfizer · Tempe, Arizona and 39 other locations · NCT07919678

• Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese

  This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).

  Recruiting Phase 3 Pfizer · Birmingham, Alabama and 3 other locations · NCT07915609

• Chromium Picolinate for Appetite and Cravings in Overweight Adults

  A remote 8-week program tests whether daily chromium picolinate helps reduce hunger and cravings in adults with BMI 25–31 who are overweight.

  Recruiting Nutrition 21, Inc. · Los Angeles, California · NCT07909109

• Maridebart cafraglutide in people who switched from weekly GLP-1 receptor agonists

  This study tests how much maridebart cafraglutide appears in the blood after people with overweight or obesity switch from weekly GLP-1 receptor agonists.

  Recruiting at 9 sites Phase 1 Amgen · Phoenix, Arizona and 8 other locations · NCT07908316

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.